UK fertility clinic releases Tinder-like app—only to select sperm donors

Swipe right for your sperm donor! The London Sperm Bank has launched its app for easy selection of donors.

The mobile app is a one-of-a-kind option for people looking for potential sperm donors. It is much like the popular dating app Tinder, where people can "swipe right" when they want to match with a potential mate.

Using the Sperm Donor App, people can filter donors on like ethnicity, occupation, personality type and eye color to name a few. Donors can even be added to a “wish list” when their characteristics match with a user’s and alerts them of the possible selection. Once selected, the user makes a payment of about $1,200 to the app and the donor sample is sent to a fertility specialist the woman is currently attending.

Such apps are able to offer a more cost effective selection process that is faster and easier for potential parents. Users can use the app in the comfort of their own home and are assured of the safety at every step by staff at the sperm bank. As the largest sperm bank in the U.K. with over 10,000 vials of sperm, the bank is able to provide a large array of donors to those looking over their multiple choices.

All of the donors featured in the app have undergone genetic and infectious testing to ensure the safety and vitality of their samples. The donor is kept private and the process has been evaluated by the British Andrology society, the British Fertility Society and the Human Fertilization and Embryology Authority.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.